- Home
- TAK vs DEO Comparison
TAK vs DEO Comparison
Compare TAK & DEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAK
- DEO
- Stock Information
- Founded
- TAK 1781
- DEO 1886
- Country
- TAK Japan
- DEO United Kingdom
- Employees
- TAK N/A
- DEO N/A
- Industry
- TAK Biotechnology: Pharmaceutical Preparations
- DEO Beverages (Production/Distribution)
- Sector
- TAK Health Care
- DEO Consumer Staples
- Exchange
- TAK Nasdaq
- DEO Nasdaq
- Market Cap
- TAK 47.3B
- DEO 53.2B
- IPO Year
- TAK N/A
- DEO N/A
- Fundamental
- Price
- TAK $13.59
- DEO $93.90
- Analyst Decision
- TAK
- DEO Strong Buy
- Analyst Count
- TAK 0
- DEO 2
- Target Price
- TAK N/A
- DEO $109.00
- AVG Volume (30 Days)
- TAK 2.8M
- DEO 1.4M
- Earning Date
- TAK 10-30-2025
- DEO 08-14-2025
- Dividend Yield
- TAK 4.00%
- DEO 4.33%
- EPS Growth
- TAK N/A
- DEO N/A
- EPS
- TAK 0.14
- DEO 1.06
- Revenue
- TAK $29,846,840,032.00
- DEO $20,245,000,000.00
- Revenue This Year
- TAK $0.01
- DEO $6.43
- Revenue Next Year
- TAK $0.49
- DEO $3.78
- P/E Ratio
- TAK $97.54
- DEO $88.84
- Revenue Growth
- TAK N/A
- DEO N/A
- 52 Week Low
- TAK $12.80
- DEO $90.50
- 52 Week High
- TAK $15.69
- DEO $132.34
- Technical
- Relative Strength Index (RSI)
- TAK 37.98
- DEO 42.59
- Support Level
- TAK $13.35
- DEO $92.02
- Resistance Level
- TAK $13.68
- DEO $93.82
- Average True Range (ATR)
- TAK 0.13
- DEO 1.27
- MACD
- TAK -0.02
- DEO -0.01
- Stochastic Oscillator
- TAK 48.58
- DEO 39.72
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
About DEO Diageo plc
Formed in 1997 through the merger of Grand Metropolitan and Guinness, Diageo is the largest distiller globally by sales. Diageo acquired some of the Seagram assets in 2001, which gave it brands such as Captain Morgan rum and Crown Royal Canadian whisky. Since then, mergers and acquisitions have mostly been bolt-on in nature, plugging gaps in the company's product and geographic portfolio. The firm has also shed noncore brands over the years, including the majority of its wine assets in 2015.